Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,290
  • Shares Outstanding, K 35,986
  • Annual Sales, $ 0 K
  • Annual Income, $ -61,040 K
  • EBIT $ -64 M
  • EBITDA $ -64 M
  • 60-Month Beta 0.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.40
  • Number of Estimates 3
  • High Estimate -0.33
  • Low Estimate -0.45
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +14.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.18 +66.81%
on 05/13/25
2.41 -18.50%
on 06/06/25
+0.77 (+64.71%)
since 05/12/25
3-Month
1.10 +78.18%
on 05/12/25
2.41 -18.50%
on 06/06/25
+0.44 (+28.95%)
since 03/12/25
52-Week
1.00 +96.00%
on 08/16/24
3.83 -48.83%
on 09/16/24
+0.42 (+27.27%)
since 06/12/24

Most Recent Stories

More News
Immuneering to Present at the Jefferies Global Healthcare Conference

IMRX : 1.96 (-7.55%)
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates

IMRX : 1.96 (-7.55%)
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference

IMRX : 1.96 (-7.55%)
Immuneering Corporation Announces Grant of Inducement Award

IMRX : 1.96 (-7.55%)
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

IMRX : 1.96 (-7.55%)
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer

IMRX : 1.96 (-7.55%)
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)

IMRX : 1.96 (-7.55%)
Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

IMRX : 1.96 (-7.55%)
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer

IMRX : 1.96 (-7.55%)
Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104; Plans to Expand Trial with Additional Arms

IMRX : 1.96 (-7.55%)

Business Summary

Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 2.26
2nd Resistance Point 2.18
1st Resistance Point 2.07
Last Price 1.96
1st Support Level 1.88
2nd Support Level 1.80
3rd Support Level 1.69

See More

52-Week High 3.83
Fibonacci 61.8% 2.75
Fibonacci 50% 2.42
Fibonacci 38.2% 2.08
Last Price 1.96
52-Week Low 1.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar